Enzon Pharmaceuticals Inc (ENZN)
0.0868
0.00 (0.00%)
USD |
OTCM |
May 10, 14:44
Enzon Pharmaceuticals Cash from Operations (Quarterly): 0.455M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.455M |
| September 30, 2023 | 0.426M |
| June 30, 2023 | 0.254M |
| March 31, 2023 | 0.17M |
| December 31, 2022 | 0.13M |
| September 30, 2022 | 0.058M |
| June 30, 2022 | -0.635M |
| March 31, 2022 | -0.212M |
| December 31, 2021 | -0.25M |
| September 30, 2021 | -0.30M |
| June 30, 2021 | 0.004M |
| March 31, 2021 | 0.045M |
| December 31, 2020 | -0.545M |
| September 30, 2020 | -0.298M |
| June 30, 2020 | 0.765M |
| March 31, 2020 | -0.302M |
| December 31, 2019 | 0.736M |
| September 30, 2019 | 6.649M |
| June 30, 2019 | -0.191M |
| March 31, 2019 | -0.289M |
| December 31, 2018 | -0.226M |
| September 30, 2018 | -0.24M |
| June 30, 2018 | -0.274M |
| March 31, 2018 | -0.238M |
| December 31, 2017 | 3.158M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.254M |
| June 30, 2017 | 3.127M |
| March 31, 2017 | 0.44M |
| December 31, 2016 | 1.375M |
| September 30, 2016 | 1.665M |
| June 30, 2016 | 1.496M |
| March 31, 2016 | -1.937M |
| December 31, 2015 | 2.471M |
| September 30, 2015 | 3.353M |
| June 30, 2015 | 4.189M |
| March 31, 2015 | 4.665M |
| December 31, 2014 | 9.987M |
| September 30, 2014 | 7.524M |
| June 30, 2014 | 6.623M |
| March 31, 2014 | 8.204M |
| December 31, 2013 | 3.898M |
| September 30, 2013 | 6.872M |
| June 30, 2013 | 0.482M |
| March 31, 2013 | 2.753M |
| December 31, 2012 | 6.391M |
| September 30, 2012 | 5.461M |
| June 30, 2012 | -2.904M |
| March 31, 2012 | -0.496M |
| December 31, 2011 | -4.023M |
| September 30, 2011 | -3.708M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-0.635M
Minimum
Jun 2022
6.649M
Maximum
Sep 2019
0.3663M
Average
0.045M
Median
Mar 2021
Cash from Operations (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -9.758M |
| Perspective Therapeutics Inc | -9.008M |
| Protalix BioTherapeutics Inc | 3.595M |
| Electromed Inc | 3.471M |
| Armata Pharmaceuticals Inc | -8.106M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | 1.305M |
| Free Cash Flow Per Share (Quarterly) | 0.0061 |
| Free Cash Flow Yield | 20.27% |